Oncternal Therapeutics Cash Conversion Cycle | ONCT

Annual Cash Conversion Cycle Oncternal Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-	-	-	-	-	-	-	-	-	-	-	-	-345	2.06	-	-

All numbers in USD currency

Maximum	Minimum	Average
2.06	-345	-172

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	51	47.5	-	44.1	54.4	-

All numbers in USD currency

Maximum	Minimum	Average
54.4	44.1	49.3

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AbbVie ABBV	284	$ 263.04	0.49 %	$ 465 B	USA
AbCellera Biologics ABCL	173	$ 11.41	2.15 %	$ 3.41 B	Canada
Фармсинтез LIFE	-15.9	-	-	-	Russia
Aclaris Therapeutics ACRS	-1.55 K	$ 5.53	6.02 %	$ 678 M	USA
ADC Therapeutics SA ADCT	-543	$ 1.09	3.74 %	$ 139 M	Schweiz
Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	52.5	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	5.06	-	-	$ 401 M	USA
ADMA Biologics ADMA	355	$ 8.61	0.16 %	$ 2.05 B	USA
Eiger BioPharmaceuticals EIGR	-50.8 K	-	-9.21 %	$ 2.55 M	USA
Fusion Pharmaceuticals FUSN	6	-	-	$ 1.41 B	Canada
Guardion Health Sciences GHSI	160	-	-0.31 %	$ 3.64 M	USA
Genocea Biosciences GNCA	24.9	-	-15.0 %	$ 3.04 M	USA
Gritstone Oncology GRTS	40.3	-	0.42 %	$ 213 M	USA
G1 Therapeutics GTHX	52.6	-	-	$ 370 M	USA
Humanigen HGEN	598	-	-81.12 %	$ 4.28 M	USA
HOOKIPA Pharma HOOK	3.33	-	-6.92 %	$ 79.4 M	USA
Intercept Pharmaceuticals ICPT	-3.11 K	-	-	$ 643 M	USA
Intra-Cellular Therapies ITCI	257	-	-	$ 13.6 B	USA
Chinook Therapeutics KDNY	0.93	-	-	$ 2.6 B	USA
Karuna Therapeutics KRTX	15.9	-	-	$ 12.2 B	USA
La Jolla Pharmaceutical Company LJPC	34.8	-	-	$ 154 M	USA
LogicBio Therapeutics LOGC	9.88	-	-	$ 229 M	USA
Lumos Pharma LUMO	13.7	-	-	$ 35.3 M	USA
Merrimack Pharmaceuticals MACK	645	-	-	$ 216 M	USA
Mirati Therapeutics MRTX	12.7	-	-	$ 3.3 B	USA
9 Meters Biopharma NMTR	27.9	-	-42.97 %	$ 1.05 M	USA
Nymox Pharmaceutical Corporation NYMX	-2.39 K	-	-19.68 %	$ 18.4 M	Canada
Opiant Pharmaceuticals OPNT	84.9	-	-	$ 109 M	USA
Orchard Therapeutics plc ORTX	-295	-	1.02 %	$ 90.8 M	Britain